Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Nonrandomized Clinical Trial.

JAMA oncology·2026
Same author

Long-Term Results of a Comparison Between 15 × 2.633 Gy and 20 × 2.0 Gy for Malignant Spinal Cord Compression in Patients with Longer Expected Survival Times.

Journal of clinical medicine·2026
Same author

Proton Beam Therapy in Prostate Cancer: Clinical Evidence, Controversies and Future Directions.

Archivos espanoles de urologia·2026
Same author

Re-evaluating Biochemical Recurrence Definitions After Radiation Therapy: Time to Move Beyond "Phoenix"?

International journal of radiation oncology, biology, physics·2026
Same author

Radiation therapy in adolescents and young adults (AYA): contemporary evidence on utilization, outcomes, late toxicities, and second malignant neoplasms - A comprehensive systematic review and synthesis.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Does size matter? A national analysis of patterns of adjuvant immunotherapy receipt and tumor size-dependent survival in pT3N0M0 clear cell renal cell carcinoma.

Urologic oncology·2026
Same journal

Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4-5 lesions.

Urologic oncology·2026
Same journal

Testis-sparing surgery for small testicular masses: Functional and oncological outcomes.

Urologic oncology·2026
Same journal

Subcapsular versus total orchiectomy in advanced prostate cancer: A systematic review and meta-analysis of clinical and patient-reported outcomes.

Urologic oncology·2026
Same journal

Featured SUO Fellow: Soum Lokeshwar, MD MBA.

Urologic oncology·2026
Same journal

Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models.

Urologic oncology·2026
See all related articles

Related Experiment Video

Updated: Nov 4, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.7K

Is hypofractionation acceptable for prostate bed radiotherapy?

Fernando López Campos1, Gemma Sancho Pardo2, Xavier Maldonado Pijoan3

  • 1Radiation Oncology Department. Hospital Universitario Ramón y Cajal, Madrid, Spain.

Urologic Oncology
|May 29, 2021
PubMed
Summary
This summary is machine-generated.

Postoperative radiotherapy may offer a cure for prostate cancer patients with disease progression after surgery. This editorial reviews hypofractionated radiotherapy efficacy and toxicity, exploring its clinical use.

Keywords:
Adjuvant and salvage radiotherapyHypofractionation radiotherapyProstate bed radiotherapy

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.1K

Related Experiment Videos

Last Updated: Nov 4, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.7K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.1K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urology

Background:

  • Radical prostatectomy is a common treatment for prostate cancer.
  • Approximately 30% of patients experience disease progression post-surgery.
  • Postoperative radiotherapy is a potentially curative option for these patients.

Purpose of the Study:

  • To assess efficacy and toxicity data of hypofractionated radiotherapy in the postoperative setting.
  • To discuss the feasibility of implementing hypofractionated radiotherapy in routine clinical practice for prostate cancer.
  • To address the need for evidence-based guidelines on optimal dosing and fractionation schedules.

Main Methods:

  • Review of existing efficacy and toxicity data for postoperative hypofractionated radiotherapy.
  • Analysis of current clinical practice standards for hypofractionated radiotherapy in nonsurgical patients.
  • Discussion of the potential benefits and challenges of adopting this treatment modality.

Main Results:

  • Limited evidence currently exists to define optimal dose and fractionation for postoperative radiotherapy.
  • Hypofractionated radiotherapy is a standard of care for nonsurgical prostate cancer patients.
  • Further research is needed to establish the role of hypofractionated radiotherapy in the postoperative setting.

Conclusions:

  • Postoperative hypofractionated radiotherapy shows potential but requires more evidence for optimal implementation.
  • Evaluating efficacy and toxicity data is crucial for integrating this approach into standard care.
  • Defining precise dose and fractionation schedules is essential for improving patient outcomes.